13F Holdings
中文EN

SINT Sintx Technologies, Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1269026 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY160.8%
TTM net income YoY5.2%
TTM EPS YoY13.0%
Revenue 3-yr CAGR10.0%
Net income 3-yr CAGR—

Margins

Gross margin59.5%
Operating margin-303.4%
Net margin-281.9%
FCF margin-279.2%
EBITDA margin-295.3%

Returns

ROE-250.4%
ROA-92.1%
ROIC (approx.)—
Asset turnover0.33x

Leverage & solvency

Liabilities / assets61.9%
Debt / equity0.00x
Current ratio1.84x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.96x
Accruals ratio-3.6%
Payout ratio—
Capex / revenue8.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.02M$2.89M$2.63M$1.56M$606,000
Cost of revenue$557,000$811,000$784,000$265,000$449,000
Gross profit$461,000$2.08M$1.84M$1.30M$157,000
R&D expense$4.59M$5.20M$8.71M$6.45M$5.89M
SG&A expense$6.20M$4.00M$4.22M$3.99M$3.60M
Operating income-$10.72M-$14.05M-$13.36M-$11.34M-$10.62M
Pretax income-$10.36M-$11.02M-$8.26M-$12.04M-$9.31M
Net income-$10.36M-$11.02M-$8.26M-$12.04M-$9.31M
EBITDA-$10.40M-$13.21M-$12.45M-$11.00M-$10.44M
EPS (basic)-6.16-14.87-443.47-54.67-37.70
EPS (diluted)-6.16-15.19-624.47-60.81-39.91
Weighted avg. shares (diluted)2.77M744,78221,786317,323250,701
Balance sheet
Cash & equivalents$4.14M$3.60M$3.34M$6.25M$14.27M
Inventory$825,000$502,000$888,000$737,000$597,000
Current assets$5.65M$4.52M$5.53M$7.21M$15.03M
PP&E, net$476,000$922,000$4.83M$5.69M$4.03M
Goodwill$302,000————
Intangibles$142,000$16,000$21,000$26,000$31,000
Total assets$9.51M$9.41M$15.37M$15.77M$21.84M
Current liabilities$3.73M$1.98M$2.91M$8.08M$2.75M
Short-term debt$7,000$32,000$46,000$160,000$509,000
Long-term debt———$368,000—
Total debt———$528,000—
Total liabilities$6.58M$5.52M$6.59M$10.07M$4.64M
Shareholders' equity$2.93M$3.89M$8.77M$5.70M$17.20M
Net debt———-$5.72M—
Shares outstanding3.97M1.34M26,603542,145247,106
Cash flow statement
Operating cash flow-$8.57M-$8.64M-$14.12M-$10.26M-$10.13M
Capital expenditure$185,000$690,000$530,000$1.41M$3.74M
Free cash flow-$8.76M-$9.33M-$14.64M-$11.67M-$13.87M
Investing cash flow$913,000-$194,000-$501,000-$1.10M-$1.66M
Financing cash flow$8.20M$9.09M$11.71M$3.34M$705,000
Depreciation & amortization$319,000$842,000$907,000$335,000$185,000
Stock-based compensation$1.39M$82,000$291,000$369,000$309,000
Share buybacks$133,000————

Free plan shows the latest 5 periods; Pro shows all 13 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.